Stay updated with breaking news from Mark Egerton. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Crinetics Pharmaceuticals, a pharmaceutical company that develops therapies for rare endocrine diseases, and Quotient Sciences, a drug...
/PRNewswire/ -- Quotient Sciences, the drug development and manufacturing accelerator, today announced that it has completed an expansion of its early-phase...
Integrated Synthesis-to-Clinic Program Will Support HTD1801's Clinical Development and Regulatory Submission Package ROCKVILLE, Md., SHENZHEN, China and NOTTINGHAM, England, Dec. 15, 2022
NOTTINGHAM, England, Oct. 18, 2022 /PRNewswire/ -- Quotient Sciences, the drug development and manufacturing accelerator, has completed the expansion of its drug substance manufacturing facility
NOTTINGHAM, England, Sept. 29, 2022 /PRNewswire/ -- Oxilio, a pioneering drug development company repurposing existing drugs to address unmet needs in cancer treatment, and Quotient Sciences